Arbutus Biopharma Corporation
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $18.0M | $36.3M | $26.3M | $30.8M | $109.3M | $52.3M | $31.8M | $36.9M |
| Accounts Receivable | $1.4M | $2.4M | $1.8M | $1.4M | $899.0K | $1.3M | $1.2M | $1.4M |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $94.5M | $127.3M | $132.0M | $151.1M | $160.7M | $127.7M | $93.8M | $129.2M |
| Property, Plant & Equipment | $32.0K | $3.3M | $4.7M | $5.1M | $6.0M | $6.9M | $8.7M | $10.1M |
| Goodwill | — | — | — | — | — | — | $0 | $22.5M |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | $0 | $43.8M |
| Total Assets | $94.6M | $131.7M | $144.4M | $195.4M | $204.5M | $137.1M | $105.5M | $227.9M |
| Liabilities | ||||||||
| Accounts Payable | $1.2M | $2.3M | $3.2M | $3.5M | $3.2M | $3.0M | $2.4M | $3.2M |
| Total Current Liabilities | $6.0M | $15.6M | $22.5M | $32.9M | $11.2M | $9.5M | $7.8M | $11.2M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | — | — | — |
| Total Liabilities | $18.0M | $34.3M | $38.4M | $58.6M | $35.0M | $35.1M | $32.8M | $27.7M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-1.38B | $-1.35B | $-1.28B | $-1.20B | $-1.13B | $-1.05B | $-970.1M | $-805.2M |
| Total Stockholders' Equity | $76.6M | $97.4M | $106.0M | $136.9M | $169.4M | $102.0M | $72.7M | $200.2M |